Vitamin B1 Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel (Direct, Indirect), By End Use (Pharmaceutical, Feed Additives, Food Additives, Dairy Products, Others), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 327.63 Million
CAGR (2026-2031)	5.03%
Fastest Growing Segment	Direct
Largest Market	North America
Market Size (2031)	USD 439.81 Million

Market Overview

The Global Vitamin B1 Market is projected to grow from USD 327.63 Million in 2025 to USD 439.81 Million by 2031 at a 5.03% CAGR. Vitamin B1, scientifically referred to as thiamine, is a water-soluble micronutrient that plays a fundamental role in intracellular glucose metabolism and the maintenance of proper nerve function. The global market for this essential vitamin is primarily propelled by its extensive utilization in the food and beverage industry for product fortification to address nutritional deficiencies, alongside its critical application in the pharmaceutical sector for treating specific medical disorders. Furthermore, the expanding animal feed sector significantly contributes to demand, as thiamine is required to optimize livestock health and metabolic performance.

Despite these strong growth factors, the market faces a substantial impediment regarding the volatility of raw material prices and supply chain concentrations which can lead to production inconsistencies. This fluctuation impacts the trade dynamics of major producing regions. According to the China Chamber of Commerce for Import and Export of Medicines and Health Products, in 2024, the export value of health food products, a sector heavily anchored by vitamin formulations, rose by 6.3 percent year on year to reach 4.28 billion United States dollars. This statistic highlights the resilient demand despite the logistical and cost challenges characterizing the current industrial landscape.

Key Market Drivers

The escalating demand for dietary supplements and nutraceuticals serves as a primary engine for the Global Vitamin B1 Market, driven by a paradigm shift towards preventive health management and immunity enhancement. Thiamine is fundamentally required for converting carbohydrates into energy and maintaining proper neurological function, making it a staple ingredient in multivitamin complexes and stress-management formulations. As consumers increasingly prioritize wellness to counteract modern high-stress lifestyles, the consumption of fortified products has surged. This trend is substantiated by recent industry data; according to WholeFoods Magazine, February 2025, citing the Council for Responsible Nutrition’s 2024 survey, 75 percent of Americans reported using dietary supplements, underscoring the sustained reliance on nutritional aids that underpin thiamine demand.

Concurrently, the expansion of the animal feed and livestock additives sector acts as a second major driver, necessitating substantial volumes of feed-grade thiamine to ensure optimal animal growth and productivity. Intensive livestock farming practices require precise nutritional fortification to prevent metabolic disorders in poultry, swine, and ruminants, thereby sustaining high adoption rates of vitamin premixes. According to DSM-Firmenich, February 2025, in the 'Integrated Annual Report 2024', the Animal Nutrition & Health business unit delivered a volume growth of 3 percent, reflecting a revitalized momentum in the additives sector. This industrial demand is supported by robust global trade flows; according to the Observatory of Economic Complexity, in October 2025, China's total vitamin exports reached 248 million United States dollars, highlighting the massive scale of the supply chain supporting these end-use industries.

Download Free Sample Report

Key Market Challenges

The volatility of raw material prices and supply chain concentrations presents a significant impediment to the expansion of the Global Vitamin B1 Market. Thiamine production is heavily consolidated within a few major industrial zones, creating a precarious dependency for global buyers. This centralization means that localized issues—such as shifts in environmental regulations, energy cost surges, or logistical disruptions—can trigger immediate and severe price instability worldwide. Such unpredictability erodes profit margins for downstream manufacturers in the pharmaceutical and food sectors, making long-term procurement strategies difficult and effectively stalling broader market investment.

Consequently, international buyers face substantial risks related to security of supply, often forcing them to maintain expensive safety stocks or face production stoppages. This vulnerability is quantified by recent industry data highlighting the extent of this dependence. According to the Institute for Feed Education and Research, in 2024, the United States relied on China for approximately 78 percent of its total vitamin imports, a figure that includes critical volumes of Vitamin B1. This high degree of concentration demonstrates how regional production variances directly hamper the consistent availability necessary for steady global market growth.

Key Market Trends

The Surge in Personalized Nutrition and Customized Vitamin Blends is reshaping the market as consumers increasingly favor tailored formulations over generic multivitamins. This trend prioritizes precision premixes where thiamine’s role in carbohydrate metabolism is optimized for specific individual energy profiles rather than mass-market deficiencies. Manufacturers are utilizing data-driven insights to create bespoke supplement packs, effectively positioning thiamine as a high-value functional component tailored to unique metabolic requirements. This shift toward individualization is quantitatively supported by consumer preferences; according to ADM, August 2025, in the 'Identifies Trends Fueling Functional Snacking' report, 59 percent of consumers expressed interest in products customized to meet their nutritional needs, incentivizing the industry to develop adaptable vitamin B1 solutions.

Simultaneously, the Rising Incorporation into Sports Nutrition and Energy Recovery Formulations is expanding thiamine demand beyond basic deficiency treatments. As the sector shifts toward comprehensive metabolic support, Vitamin B1 is increasingly utilized to facilitate glucose-to-energy conversion for endurance athletes, distinguishing it from general wellness applications. This integration is visible in recovery beverages that highlight B-vitamin complexes as essential for performance optimization and rapid glycogen replenishment. This segment's commercial strength is evident in recent financial performance; according to Glanbia, February 2025, in the '2024 Full Year Results', the Optimum Nutrition brand delivered a revenue growth of 7.5 percent constant currency, reflecting the sustained consumer appetite for performance products relying on micronutrient fortification.

Segmental Insights

The Direct segment represents the fastest-growing category in the Global Vitamin B1 Market, driven by an increasing preference among manufacturers for streamlined procurement strategies. Industrial buyers in the pharmaceutical and food sectors are prioritizing direct sourcing to ensure optimal supply chain transparency and rigorous quality control. This approach enables companies to negotiate better pricing and collaborate on customized nutrient formulations that comply with safety standards from organizations such as the U.S. Food and Drug Administration. By eliminating intermediaries, businesses can maintain consistent product integrity, thereby accelerating the expansion of this segment.

Regional Insights

North America leads the Global Vitamin B1 Market due to substantial demand within the dietary supplement and fortified food sectors. The region benefits from high consumer awareness regarding preventative healthcare and nutritional wellness. Furthermore, regulatory bodies such as the U.S. Food and Drug Administration enforce strict manufacturing and safety standards, which strengthens consumer trust and supports market stability. The widespread consumption of thiamine-enriched cereals and grains, combined with a strong functional beverage industry, continues to drive steady product adoption across the United States and Canada.

Recent Developments

• In July 2025, Huazhong Pharmaceutical Co., Ltd. suspended the quotation and production of Vitamin B1 to facilitate scheduled maintenance on its manufacturing lines. This operational pause by one of the major producers in the sector led to a reduction in market availability and contributed to firmer pricing trends during the period. The suspension affected the supply of thiamine for various applications, including animal feed additives and pharmaceutical formulations, as downstream buyers adjusted to the temporary tightening of global inventory.
• In April 2025, University Hospitals Cleveland Medical Center commenced recruitment for a Phase 2 clinical trial evaluating the efficacy of benfotiamine, a synthetic derivative of Vitamin B1, in treating early-stage Alzheimer’s disease. Funded by the National Institute on Aging, the multi-site study aimed to determine whether high doses of this thiamine precursor could slow cognitive decline in patients with mild cognitive impairment. The research focused on addressing thiamine deficiency in the brain, which is often observed in Alzheimer’s patients, by utilizing a formulation designed to improve absorption and bioavailability compared to standard thiamine supplements.
• In April 2025, researchers at the University of California, Riverside, published findings confirming a long-standing hypothesis regarding the chemical behavior of Vitamin B1. The scientific team successfully stabilized a carbene intermediate of thiamine in a water-based environment, a feat previously considered impossible due to the molecule's extreme reactivity. This discovery validated a theory originally proposed in 1958 and demonstrated that these intermediates could exist in biological settings. The breakthrough offered new possibilities for using Vitamin B1 analogs in sustainable chemical synthesis and provided deeper insights into the vitamin's metabolic mechanisms.
• In February 2024, DSM-Firmenich announced the initiation of a strategic process to carve out and separate its Animal Nutrition & Health business from the wider group. The company stated that this decision was driven by the need to minimize exposure to earnings volatility in the global vitamins market, which had experienced unprecedented challenges. By separating this division, which produces essential feed ingredients including Vitamin B1, the organization aimed to allow the business to realize its full potential under a different ownership structure. The move also enabled the parent company to focus its resources on its health, nutrition, and beauty segments.

Key Market Players

• Jiangxi Tianxin Pharmaceutical Co., Ltd.
• Xinfa Pharmaceutical Co., Ltd.
• Brother Enterprises Holding Co., Ltd
• Huazhong Pharmaceutical Company Limited
• dsm-firmenich

By Sales Channel	By End Use	By Region
Direct Indirect	Pharmaceutical Feed Additives Food Additives Dairy Products Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Vitamin B1 Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Vitamin B1 Market, By Sales Channel:

• Direct
• Indirect

• Vitamin B1 Market, By End Use:

• Pharmaceutical
• Feed Additives
• Food Additives
• Dairy Products
• Others

• Vitamin B1 Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE